US Patent Issued to DANA-FARBER CANCER INSTITUTE on Oct. 28 for "Methods of treating anemia in myelodysplastic syndromes" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,572, issued on Oct. 28, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Methods of treating anemia in myelodysplastic syndromes" was invented by Laurie H. Glimcher (Boston) and Mahesh Raundhal (Jamaica Plain, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to methods for treating red blood cell disorders, such as an MDS and/or an anemia, by down-regulating IL-22 signaling."

The patent was filed on March 2, 2022, under Application No. 18/280,100.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...